Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases
Not Applicable
- Conditions
- Chronic Rheumatic Diseases
- Registration Number
- NCT02260323
- Lead Sponsor
- Chengdu PLA General Hospital
- Brief Summary
To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic rheumatic disease
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- were between 18 and 35 years of age
- without use of TCM in the previous 3 months
- and had a Steinbrocker functional status of class I, II, or III
Exclusion Criteria
- previous general health conditions disallowed their use of TCM
- were pregnant
- lack of motivation, remote from home, time-consuming,intervention, or other personal difficulties
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Changes from baseline in HBCS(Hill-Bone Compliance Scale) score at 48 weeks at 0 week, 12 weeks, 24 weeks, 48 weeks Changes from baseline in MARS(Medication Adherence Rating Scale) score at 48 weeks at 0 week, 12 weeks, 24 weeks, 48 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms do patient-tailored anti-arthritis TCM herbs target in rheumatoid arthritis and juvenile idiopathic arthritis?
How does compliance with patient-tailored TCM DMARDs compare to conventional DMARDs like methotrexate in young rheumatic disease patients?
Which biomarkers (e.g., cytokine profiles, genetic markers) predict adherence to TCM therapies in systemic lupus erythematosus and juvenile dermatomyositis?
What are the safety profiles and adverse event management strategies for patient-tailored TCM DMARDs in pediatric rheumatology?
Are there synergistic effects of combining patient-tailored TCM herbs with biologic DMARDs like TNF inhibitors in treating chronic rheumatic diseases?
Trial Locations
- Locations (1)
General Hospital of Chengdu Military Area Command PLA
🇨🇳Chengdu, Sichuan, China
General Hospital of Chengdu Military Area Command PLA🇨🇳Chengdu, Sichuan, China
